Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects

Neuropsychopharmacology

Volumn 31, Issue 8, 2006, Pages 1822-1831

  Herringa, Ryan J ^a   Roseboom, Patrick H ^a,b   Kalin, Ned H ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

CRH; Depression; Gender; Mental illness; Neuropeptides; Psychopathology

Indexed keywords

BINDING PROTEIN; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA;

AMYGDALOID NUCLEUS; ANATOMY; ARTICLE; BIPOLAR DISORDER; BRAIN TISSUE; CADAVER; CONTROLLED STUDY; EXPOSURE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; STRESS; TEMPORAL LOBE;

ADULT; AGED; AMYGDALA; BIPOLAR DISORDER; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTMORTEM CHANGES; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 33746311966     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301038     Document Type: Article

References (45)

1. Allendoerfer KL, Shatz CJ (1994). The subplate, a transient neocortical structure: its role in the development of connections between thalamus and cortex. Annu Rev Neurosci 17: 185-218.
2. Anand A, Shekhar A (2003). Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann NY Acad Sci 985: 370-388.
3. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160: 1-12.
4. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW (1995). Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol 16: 362-382.
5. Behan DP, Potter E, Lewis KA, Jenkins NA, Copeland N, Lowry PJ et al (1993). Cloning and structure of the human corticotrophin releasing factor- binding protein gene (CRHBP). Genomics 16: 63-68.
6. Brown GW, Bifulco A, Harris TO (1987). Life events, vulnerability and onset of depression: some refinements. Br J Psychiatry 150: 30-42.
7. Choate JV, Slayden OD, Resko JA (1998). Immunocytochemical localization of androgen receptors in brains of developing and adult male rhesus monkeys. Endocrine 8: 51-60.
8. Claes S, Villafuerte S, Forsgren T, Sluijs S, Del-Favero J, Adolfsson R et al (2003). The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden. Biol Psychiatry 54: 867-872.
9. Davidson RJ (2002). Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry 51: 68-80.
10. Drevets WC, Raichle ME (1995). Positron emission tomographic imaging studies of human emotional disorders. In: Gazzaniga MS (ed). The Cognitive Neurosciences. MIT: Cambridge, MA. pp 1153-1164.
11. Dunn AJ, Berridge CW (1990). Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 15: 71-100.
12. Dunner DL, Patrick V, Fieve RR (1979). Life events at the onset of bipolar affective illness. Am J Psychiatry 136: 508-511.
13. Hammen C, Davila J, Brown G, Ellicott A, Gitlin M (1992). Psychiatric history and stress: predictors of severity of unipolar depression. J Abnorm Psychol 101: 45-52.
14. Herringa RJ, Nanda SA, Hsu DT, Roseboom PH, Kalin NH (2004). The effects of acute stress on the regulation of central and basolateral amygdala CRF-binding protein gene expression. Brain Res Mol Brain Res 131: 17-25.
15. Hsu DT, Chen FL, Takahashi LK, Kalin NH (1998). Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res 788: 305-310.
16. Hucks D, Lowther S, Crompton MR, Katona CL, Horton RW (1997). Corticotropin-releasing factor binding sites in cortex of depressed suicides. Psychopharmacology (Berl) 134: 174-178.
17. Kalin NH (1985). Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys. Fed Proc 44: 249-253.
18. Kalin NH, Shelton SE, Davidson RJ (2000). Cerebrospinal fluid corticotropin-releasing hormone levels are elevated in monkeys with patterns of brain activity associated with fearful temperament. Biol Psychiatry 47: 579-585.
19. Kalin NH, Shelton SE, Kraemer GW, McKinney WT (1983). Corticotropin-releasing factor administered intraventricularly to rhesus monkeys. Peptides 4: 217-220.
20. Koob GF, Heinrichs SC (1999). A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848: 141-152.
21. Kostovic I, Rakic P (1990). Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J Comp Neurol 297: 441-470.
22. Leake A, Perry EK, Perry RH, Fairbairn AF, Ferrier IN (1990). Cortical concentrations of corticotropin-releasing hormone and its receptor in alzheimer type dementia and major depression. Biol Psychiatry 28: 603-608.
23. Lombardo KA, Herringa RJ, Balachandran JS, Hsu DT, Bakshi VP, Roseboom PH et al (2001). Effects of acute and repeated restraint stress on corticotropin-releasing hormone binding protein mRNA in rat amygdala and dorsal hippocampus. Neurosci Lett 302: 81-84.
24. Mai JK, Assheuer J, Paxinos G (1997). Atlas of the Human Brain. Academic Press: San Diego.
25. Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO et al (2004). Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24: 1478-1485.
26. Michael RP, Clancy AN, Zumpe D (1995). Distribution of androgen receptor-like immunoreactivity in the brains of cynomolgus monkeys. J Neuroendocrinol 7: 713-719.
27. Mitchell AJ (1998). The role of corticotropin releasing factor in depressive illness: a critical review. Neurosci Biobehav Rev 22: 635-651.
28. Mrzljak L, Uylings HB, Kostovic I, Van Eden CG (1988). Prenatal development of neurons in the human prefrontal cortex: I. A qualitative Golgi study. J Comp Neurol 271: 355-386.
29. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988). Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45: 577-579.
30. Norman RM, Malla AK (1993). Stressful life events and schizophrenia. I: A review of the research. Br J Psychiatry 162: 161-166.
31. Norman RM, Malla AK (1994). A prospective study of daily stressors and symptomatology in schizophrenic patients. Soc Psychiatry Psychiatr Epidemiol 29: 244-249.
32. Osterlund MK, Gustafsson JA, Keller E, Hurd YL (2000). Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab 85: 3840-3846.
33. Perlman WR, Webster MJ, Kleinman JE, Weickert CS (2004). Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol Psychiatry 56: 844-852.
34. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW (1992). The central distribution of corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 89: 4192-4196.
35. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF (1995). Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 152: 1372-1376.
36. Salem JE, Kring AM (1998). The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia. Clin Psychol Rev 18: 795-819.
37. Schwartz CE, Wright CI, Shin LM, Kagan J, Whalen PJ, McMullin KG et al (2003). Differential amygdalar response to novel versus newly familiar neutral faces: a functional MRI probe developed for studying inhibited temperament. Biol Psychiatry 53: 854-862.
38. Speert DB, McClennen SJ, Seasholtz AF (2002). Sexually dimorphic expression of corticotropin-releasing hormone-binding protein in the mouse pituitary. Endocrinology 143: 4730-4741.
39. Tamminga CA (1997). Gender and schizophrenia. J Clin Psychiatry 58(Suppl 15): 33-37.
40. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB (2005). Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 57: 252-260.
41. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH (2000). The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr Res 44: 151-155.
42. van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C et al (2004). Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta. Mol Endocrinol 18: 2908-2923.
43. Weinberger DR (1995). From neuropathology to neurodevelopment. Lancet 346: 552-557.
44. Young LT, Bezchlibnyk YB, Chen B, Wang JF, MacQueen GM (2004). Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment. Biol Psychiatry 55: 570-577.
45. Zobel AW, Nickel T, Kunzel HE, Ackl N, Sonntag A, Ising M et al (2000). Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 34: 171-181.